164 related articles for article (PubMed ID: 15471961)
1. 17beta-estradiol-dependent activation of signal transducer and activator of transcription-1 in human fetal osteoblasts is dependent on Src kinase activity.
Kennedy AM; Shogren KL; Zhang M; Turner RT; Spelsberg TC; Maran A
Endocrinology; 2005 Jan; 146(1):201-7. PubMed ID: 15471961
[TBL] [Abstract][Full Text] [Related]
2. Signal transducers and activators of transcription as downstream targets of nongenomic estrogen receptor actions.
Björnström L; Sjöberg M
Mol Endocrinol; 2002 Oct; 16(10):2202-14. PubMed ID: 12351686
[TBL] [Abstract][Full Text] [Related]
3. Role of estrogen receptors, PKC and Src in ERK2 and p38 MAPK signaling triggered by 17β-estradiol in skeletal muscle cells.
Ronda AC; Buitrago C; Boland R
J Steroid Biochem Mol Biol; 2010 Oct; 122(4):287-94. PubMed ID: 20478382
[TBL] [Abstract][Full Text] [Related]
4. Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells.
Proietti C; Salatino M; Rosemblit C; Carnevale R; Pecci A; Kornblihtt AR; Molinolo AA; Frahm I; Charreau EH; Schillaci R; Elizalde PV
Mol Cell Biol; 2005 Jun; 25(12):4826-40. PubMed ID: 15923602
[TBL] [Abstract][Full Text] [Related]
5. Estrogen negatively regulates epidermal growth factor (EGF)-mediated signal transducer and activator of transcription 5 signaling in human EGF family receptor-overexpressing breast cancer cells.
Boerner JL; Gibson MA; Fox EM; Posner ED; Parsons SJ; Silva CM; Shupnik MA
Mol Endocrinol; 2005 Nov; 19(11):2660-70. PubMed ID: 15976008
[TBL] [Abstract][Full Text] [Related]
6. STAT activation by the PDGF receptor requires juxtamembrane phosphorylation sites but not Src tyrosine kinase activation.
Sachsenmaier C; Sadowski HB; Cooper JA
Oncogene; 1999 Jun; 18(24):3583-92. PubMed ID: 10380880
[TBL] [Abstract][Full Text] [Related]
7. Activation of the Janus kinase/STAT (signal transducer and activator of transcription) signal transduction pathway by interleukin-6-type cytokines promotes osteoblast differentiation.
Bellido T; Borba VZ; Roberson P; Manolagas SC
Endocrinology; 1997 Sep; 138(9):3666-76. PubMed ID: 9275051
[TBL] [Abstract][Full Text] [Related]
8. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
9. Ugonin K-stimulated osteogenesis involves estrogen receptor-dependent activation of non-classical Src signaling pathway and classical pathway.
Lee CH; Huang YL; Liao JF; Chiou WF
Eur J Pharmacol; 2012 Feb; 676(1-3):26-33. PubMed ID: 22192930
[TBL] [Abstract][Full Text] [Related]
10. 17beta-estradiol inhibits the production of interferon-induced protein of 10 kDa by human keratinocytes.
Kanda N; Watanabe S
J Invest Dermatol; 2003 Mar; 120(3):411-9. PubMed ID: 12603854
[TBL] [Abstract][Full Text] [Related]
11. 17beta-estradiol inhibits the production of RANTES in human keratinocytes.
Kanda N; Watanabe S
J Invest Dermatol; 2003 Mar; 120(3):420-7. PubMed ID: 12603855
[TBL] [Abstract][Full Text] [Related]
12. Induction of osteoblast differentiation by selective activation of kinase-mediated actions of the estrogen receptor.
Kousteni S; Almeida M; Han L; Bellido T; Jilka RL; Manolagas SC
Mol Cell Biol; 2007 Feb; 27(4):1516-30. PubMed ID: 17158928
[TBL] [Abstract][Full Text] [Related]
13. Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells.
Fox EM; Bernaciak TM; Wen J; Weaver AM; Shupnik MA; Silva CM
Mol Endocrinol; 2008 Aug; 22(8):1781-96. PubMed ID: 18550772
[TBL] [Abstract][Full Text] [Related]
14. [Effect of nocodazole on the activation of transcription factors STAT1 and STAT3 in A431 cells].
Vasilenko KP; Burova EB; Vinogradova NA; Nikol'skiĭ NN
Tsitologiia; 2004; 46(12):1025-9. PubMed ID: 15747831
[TBL] [Abstract][Full Text] [Related]
15. The Src kinase pathway promotes tamoxifen agonist action in Ishikawa endometrial cells through phosphorylation-dependent stabilization of estrogen receptor (alpha) promoter interaction and elevated steroid receptor coactivator 1 activity.
Shah YM; Rowan BG
Mol Endocrinol; 2005 Mar; 19(3):732-48. PubMed ID: 15528270
[TBL] [Abstract][Full Text] [Related]
16. Regulation of signal transducer and activator of transcription 1 (STAT1) and STAT1-dependent genes by RET/PTC (rearranged in transformation/papillary thyroid carcinoma) oncogenic tyrosine kinases.
Hwang ES; Kim DW; Hwang JH; Jung HS; Suh JM; Park YJ; Chung HK; Song JH; Park KC; Park SH; Yun HJ; Kim JM; Shong M
Mol Endocrinol; 2004 Nov; 18(11):2672-84. PubMed ID: 15297606
[TBL] [Abstract][Full Text] [Related]
17. Estrogen activation of cyclic adenosine 5'-monophosphate response element-mediated transcription requires the extracellularly regulated kinase/mitogen-activated protein kinase pathway.
Wade CB; Dorsa DM
Endocrinology; 2003 Mar; 144(3):832-8. PubMed ID: 12586759
[TBL] [Abstract][Full Text] [Related]
18. MEK/ERK and signal transducer and activator of transcription signaling pathways modulate oncostatin M-stimulated CCL2 expression in human osteoblasts through a common transcription factor.
Lin SK; Kok SH; Yeh FT; Kuo MY; Lin CC; Wang CC; Goldring SR; Hong CY
Arthritis Rheum; 2004 Mar; 50(3):785-93. PubMed ID: 15022320
[TBL] [Abstract][Full Text] [Related]
19. Identification of estrogen receptor ligands leading to activation of non-genomic signaling pathways while exhibiting only weak transcriptional activity.
Wessler S; Otto C; Wilck N; Stangl V; Fritzemeier KH
J Steroid Biochem Mol Biol; 2006 Jan; 98(1):25-35. PubMed ID: 16203130
[TBL] [Abstract][Full Text] [Related]
20. Estradiol represses prolactin-induced expression of Na+/taurocholate cotransporting polypeptide in liver cells through estrogen receptor-alpha and signal transducers and activators of transcription 5a.
Cao J; Wood M; Liu Y; Hoffman T; Hyde J; Park-Sarge OK; Vore M
Endocrinology; 2004 Apr; 145(4):1739-49. PubMed ID: 14684617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
